about
sameAs
Review of intervention studies on depression in persons with multiple sclerosis.Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis.Perceived needs and satisfaction with care in people with multiple sclerosis: a two-year prospective studyBrain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosisGlobal N-acetylaspartate declines even in benign multiple sclerosisInterferon-gamma activated calcium influx in peripheral blood lymphocytes from patients with primary and secondary progressive multiple sclerosisPatient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale-29.Community services in multiple sclerosis: still a matter of chance.Circulating microRNAs involved in multiple sclerosis.Sex differences in autoimmune diseases.The emerging role of MRI in multiple sclerosis and the new diagnostic criteria.Estrogen and testosterone therapies in multiple sclerosis.Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activityQuantitative measures detect sensory and motor impairments in multiple sclerosis.Microbiome manipulation modifies sex-specific risk for autoimmunity.Hematopoietic stem cell transplantation for multiple sclerosis: finding equipoise.Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis.Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging.Internet portal use in an academic multiple sclerosis center.Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment.FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value.Repetitive element hypermethylation in multiple sclerosis patients.Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.Prognosis of multiple sclerosis: clinical factors predicting the late evolution for an early treatment decision.Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?Cladribine: an investigational immunomodulatory agent for multiple sclerosis.Gene expression studies in multiple sclerosis.Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors.Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease durationXY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis.Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.Gender issues in multiple sclerosis: an update.Gene expression profiling in multiple sclerosis brain.Multiple sclerosis: a supplement on the disease state, current therapies, and investigational treatments.Relapsing and progressive forms of multiple sclerosis: insights from pathology.Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.The importance of studying sex differences in disease: The example of multiple sclerosis.A qualitative investigation of adaptation in older individuals with multiple sclerosis.Gait and balance deterioration over a 12-month period in multiple sclerosis patients with EDSS scores ≤ 3.0.Reliability and validity of the multiple sclerosis quality of life inventory in older individuals.
P2860
Q30542657-0B556B2E-428C-4F31-B120-B36262517DCAQ33194284-81E4690A-CF20-45E3-97E2-376CD2A3DE8CQ33372585-4A35EEB8-A651-4912-94FC-B854CEBAC258Q33533554-2B472238-556D-406F-8F1F-AB641F664A72Q33725131-9577A1E5-72AF-461A-94A7-B9E10BCAEC42Q33735608-1E68062A-911B-44F4-95B3-826AA33B30C1Q33887859-5897472F-DAF1-4573-BC10-344AB12EDF38Q34083596-CDE25CDC-6125-41B0-A6AD-D3D35D23AADEQ34246016-90B9F08B-51DE-4FD8-84EE-DEAD4EEC43FCQ34498866-B681F59F-3FE9-4FEA-84DD-086677069FCCQ34590306-00951EE8-3FE5-4371-B3A5-83EE6E8FD4C2Q34610594-985E3079-51EB-4D0D-A5AB-7782A2FEE1D0Q34658763-948928A1-0268-4C80-A6AB-B58C8E6B7F0BQ34959472-7B1DEC36-DF31-451B-A162-E71CB4DA9800Q35203778-17BBED09-B13D-487D-B3FC-D94D2F92289FQ35204109-2B8ED08A-6182-43C4-AACE-8A31C93BA5B2Q35455055-3901AC27-ADF5-4B16-A94A-EB0B3EDA4493Q35483352-F8DFBC25-A28A-48DF-BA87-F8689E70E381Q35619064-18FA646E-0AC2-447B-89CF-0984E5A84641Q35629319-0505E4AD-28E0-4C8B-8860-CF1C8B71333AQ35876398-C03AF76A-4FEB-4234-9D7E-85899A48E584Q36055884-8304E37A-0B69-444E-AEC0-3933F9866F6DQ36318089-ECF77899-8665-4481-8458-D2676D2A79BDQ36419573-FDD00063-A056-4A6F-A44D-91E0B424CC3CQ36432500-7BB49EEF-1D1F-4270-B7CD-ED09E241627AQ36598122-5737F76B-75AC-48D7-B3B6-9AFB241881CBQ36731890-CCF0E345-C5B7-458E-8A24-67D7429DA859Q36920474-5F49A649-F92C-4083-BEF2-A409716A5A19Q37303007-AF981EB6-BD5D-49C3-B015-FCA6ADEF05C1Q37599969-5E16E062-5E19-4132-A790-967DA43AC946Q37800214-4C4E011E-9C87-46C7-B3ED-D3FA52B19959Q37813691-62FCCAE9-D4BC-4DFD-8B04-57EA3CAE4EDDQ37819329-C5D6F013-F57A-4C6C-B08F-08314C9FB4AFQ37867269-BFCE8140-E99B-417E-A817-F0F0F1C42273Q38203770-0BCB3427-1E71-46B6-986E-E90C9B5C623BQ38625426-6E2DCAAB-289B-430E-A717-67174D7926BAQ39015338-6B87D64C-AC7E-4B35-98A0-C5DF921E2D55Q40001240-47E4EA14-C37F-485F-92A6-6A9A230A2DC8Q40325538-457F3CF4-43C4-471A-AD55-D62600238755Q40575230-ABB86E2B-67DF-4423-9E0B-BBABF2EE4FB2
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Natural history of multiple sclerosis
@ast
Natural history of multiple sclerosis
@en
Natural history of multiple sclerosis
@en-gb
Natural history of multiple sclerosis.
@nl
type
label
Natural history of multiple sclerosis
@ast
Natural history of multiple sclerosis
@en
Natural history of multiple sclerosis
@en-gb
Natural history of multiple sclerosis.
@nl
altLabel
Natural history of multiple sclerosis.
@en
prefLabel
Natural history of multiple sclerosis
@ast
Natural history of multiple sclerosis
@en
Natural history of multiple sclerosis
@en-gb
Natural history of multiple sclerosis.
@nl
P2860
P356
P1433
P1476
Natural history of multiple sclerosis
@en
Natural history of multiple sclerosis.
@en
P2093
Brian G. Weinshenker
Weinshenker BG
P2860
P356
10.1002/ANA.410360704
P577
1994-01-01T00:00:00Z